Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Over 200 patients on Suboxone

By Mindo - 29th Aug 2019 | 14 views

In April 203 patients attended for opioid substitution treatment (OST) with buprenorphine/naloxone (Suboxone), according to information provided by the HSE.

A HSE spokesperson said addiction services in each Community Healthcare Organisation (CHO) are prescribing the medication. 

Suboxone, the brand name for buprenorphine/naloxone, is an alternative substitution treatment for opioid drug dependence.

New regulations were introduced in November 2017 to provide access to certain buprenorphine-based medicinal products in the OST system on the same statutory basis as methadone.

GPs contacted by the Medical Independent said the new system was working well. However, they did not predict a major shift of patients from methadone to Suboxone.

At the end of May, there were 281 level 1 doctors (who can treat stabilised, opiate-dependent patients) prescribing in the OST system, of which less than 10 prescribed buprenorphine/naloxone.

As of the same date, there were 86 level 2 doctors (who can initiate OST treatment) prescribing in the OST system, of which 21 prescribed buprenorphine/naloxone.

In April there were 10,464 patients attending for methadone treatment, according to the HSE.

The extension of access to buprenorphine/naloxone has been welcomed by the ICGP.

“Having it available nationally allows for increased patient choice and also facilitates its use as the medication of choice for certain addictions such as codeine and opiate analgesic medications,” said Director of the ICGP Substance Misuse Programme Dr Ide Delargy.

“[The] ICGP is very supportive of this initiative and acknowledges the role that GPs have in the roll-out of this successful programme.”

At the end of 2017, there were 110 patients in receipt of Suboxone, 144 by mid-2018 and over 200 by April this year.  

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read